08:02 AM EST, 01/08/2025 (MT Newswires) -- Absci ( ABSI ) said Wednesday it has entered into a strategic collaboration with Advanced Micro Devices ( AMD ) to deploy AMD Instinct accelerators and ROCm software to power AI drug discovery workloads, including Absci's ( ABSI ) advanced de novo antibody design models.

As part of the collaboration, Advanced Micro Devices ( AMD ) is also investing $20 million in Absci ( ABSI ), structured as a private investment in public equity.

The collaboration will be featured at the 43rd Annual J.P. Morgan Healthcare Conference on Jan. 15, Absci ( ABSI ) said.